Influence of Fc Modifications and IgG Subclass on Biodistribution of Humanized Antibodies Targeting L1CAM

Abstract

Immuno-PET is a powerful tool to noninvasively characterize the in vivo biodistribution of engineered antibodies. <b>Methods:</b> L1 cell adhesion molecule-targeting humanized (HuE71) IgG₁ and IgG₄ antibodies bearing identical variable heavy- and light-chain sequences but different fragment crystallizable (Fc) portions were radiolabeled with ⁸⁹Zr, and the in vivo biodistribution was studied in SKOV3 ovarian cancer xenografted nude mice. <b>Results:</b> In addition to showing uptake in L1 cell adhesion molecule-expressing SKOV3 tumors, as does its parental counterpart HuE71 IgG₁, the afucosylated variant having enhanced Fc-receptor affinity showed high nonspecific uptake in lymph nodes. On the other hand, aglycosylated HuE71 IgG₁ with abrogated Fc-receptor binding did not show lymphoid uptake. The use of the IgG₄ subclass showed high nonspecific uptake in the kidneys, which was prevented by mutating serine at position 228 to proline in the hinge region of the IgG₄ antibody to mitigate in vivo fragment antigen-binding arm exchange. <b>Conclusion:</b> Our findings highlight the influence of Fc modifications and the choice of IgG subclass on the in vivo biodistribution of antibodies and the potential outcomes thereof.